Search Results - "McElroy, John F." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance

Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance

by Tam, Joseph, Cinar, Resat, Liu, Jie, Godlewski, Grzegorz, Wesley, Daniel, Jourdan, Tony, Szanda, Gergő, Mukhopadhyay, Bani, Chedester, Lee, Liow, Jeih-San, Innis, Robert B., Cheng, Kejun, Rice, Kenner C., Deschamps, Jeffrey R., Chorvat, Robert J., McElroy, John F., Kunos, George
Published in Cell metabolism (08.08.2012)

Get full text

Journal Article

Behavioral and Pharmacological Validation of the Gerbil Forced-Swim Test: Effects of Neurokinin-1 Receptor Antagonists

Behavioral and Pharmacological Validation of the Gerbil Forced-Swim Test: Effects of Neurokinin-1 Receptor Antagonists

by Wallace-Boone, Tanya L, Newton, Amy E, Wright, Robert N, Lodge, Nicholas J, McElroy, John F
Published in Neuropsychopharmacology (New York, N.Y.) (01.07.2008)

Get full text

Journal Article

JD-5006 and JD-5037: Peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities

JD-5006 and JD-5037: Peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities

by Chorvat, Robert J., Berbaum, Jennifer, Seriacki, Kristine, McElroy, John F.
Published in Bioorganic & medicinal chemistry letters (01.10.2012)

Get full text

Journal Article

Anxiolytic-Like Effects of the Corticotropin-Releasing Factor1 (CRF1) Antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] Administered Acutely or Chronically at Doses Occupying Central CRF1 Receptors in Rats

Anxiolytic-Like Effects of the Corticotropin-Releasing Factor1 (CRF1) Antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] Administered Acutely or Chronically at Doses Occupying Central CRF1 Receptors in Rats

by Lelas, Snjezana, Wong, Harvey, Li, Yu-Wen, Heman, Karen L, Ward, Kathryn A, Zeller, Kim L, Sieracki, Kristine K, Polino, Joseph L, Godonis, Helen E, Ren, Shelly X, Yan, Xiao-Xin, Arneric, Stephen P, Robertson, David W, Hartig, Paul R, Grossman, Scott, Trainor, George L, Taub, Rebecca A, Zaczek, Robert, Gilligan, Paul J, McElroy, John F
Published in The Journal of pharmacology and experimental therapeutics (01.04.2004)

Get full text

Journal Article

Synthesis and Structure−Activity Relationships of 8-(Pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: Potent, Orally Bioavailable Corticotropin Releasing Factor Receptor-1 (CRF1) Antagonists

Synthesis and Structure−Activity Relationships of 8-(Pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: Potent, Orally Bioavailable Corticotropin Releasing Factor Receptor-1 (CRF1) Antagonists

by Gilligan, Paul J, Clarke, Todd, He, Liqi, Lelas, Snjezana, Li, Yu-Wen, Heman, Karen, Fitzgerald, Lawrence, Miller, Keith, Zhang, Ge, Marshall, Anne, Krause, Carol, McElroy, John F, Ward, Kathyrn, Zeller, Kim, Wong, Harvey, Bai, Steven, Saye, Joanne, Grossman, Scott, Zaczek, Robert, Arneric, Stephen P, Hartig, Paul, Robertson, David, Trainor, George
Published in Journal of medicinal chemistry (14.05.2009)

Get full text

Journal Article

The CRF1 receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats

The CRF1 receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats

by MCELROY, John F, WARD, Kathryn A, ZELLER, Kim L, JONES, Keith W, GILLIGAN, Paul J, LIQI HE, LELAS, Sniezana
Published in Psychopharmacologia (01.12.2002)

Get full text

Journal Article

Effects of CRF1 receptor antagonists and benzodiazepines in the Morris water maze and delayed non-matching to position tests

Effects of CRF1 receptor antagonists and benzodiazepines in the Morris water maze and delayed non-matching to position tests

by HOGAN, John B, HODGES, Donald B, LELAS, Snjezana, GILLIGAN, Paul J, MCELROY, John F, LINDNER, Mark D
Published in Psychopharmacologia (01.04.2005)

Get full text

Journal Article

The anxiolytic CRF1 antagonist DMP696 fails to function as a discriminative stimulus and does not substitute for chlordiazepoxide in rats

The anxiolytic CRF1 antagonist DMP696 fails to function as a discriminative stimulus and does not substitute for chlordiazepoxide in rats

by LELAS, Snjezana, ZELLER, Kim L, WARD, Kathryn A, MCELROY, John F
Published in Psychopharmacologia (01.04.2003)

Get full text

Journal Article

Novel, highly potent, selective 5-HT2A/D2 receptor antagonists as potential atypical antipsychotics

Novel, highly potent, selective 5-HT2A/D2 receptor antagonists as potential atypical antipsychotics

by TAEKYU LEE, ROBICHAUD, Albert J, BOYLE, Kristopher E, YIMIN LU, ROBERTSON, David W, MILLER, Keith J, FITZGERALD, Larry W, MCELROY, John F, LARGENT, Brian L
Published in Bioorganic & medicinal chemistry letters (24.02.2003)

Get full text

Journal Article

Adverse effects of gabapentin and lack of anti-allodynic efficacy of amitriptyline in the streptozotocin model of painful diabetic neuropathy

Adverse effects of gabapentin and lack of anti-allodynic efficacy of amitriptyline in the streptozotocin model of painful diabetic neuropathy

by Lindner, Mark D, Bourin, Clotilde, Chen, Ping, McElroy, John F, Leet, John E, Hogan, John B, Stock, David A, Machet, Frederic
Published in Experimental and clinical psychopharmacology (01.02.2006)

Get more information

Journal Article

Synthesis, Structure−Activity Relationships, and in Vivo Properties of 3,4-Dihydro-1H-pyrido[2,3-b]pyrazin-2-ones as Corticotropin-Releasing Factor-1 Receptor Antagonists

Synthesis, Structure−Activity Relationships, and in Vivo Properties of 3,4-Dihydro-1H-pyrido[2,3-b]pyrazin-2-ones as Corticotropin-Releasing Factor-1 Receptor Antagonists

by Dzierba, Carolyn D, Takvorian, Amy G, Rafalski, Maria, Kasireddy-Polam, Padmaja, Wong, Harvey, Molski, Thaddeus F, Zhang, Ge, Li, Yu-Wen, Lelas, Snjezana, Peng, Yong, McElroy, John F, Zaczek, Robert C, Taub, Rebecca A, Combs, Andrew P, Gilligan, Paul J, Trainor, George L
Published in Journal of medicinal chemistry (04.11.2004)

Get full text

Journal Article

Novel piperidine .sigma. receptor ligands as potential antipsychotic drugs

Novel piperidine .sigma. receptor ligands as potential antipsychotic drugs

by Gilligan, Paul J, Cain, Gary A, Christos, Thomas E, Cook, Leonard, Drummond, Spencer, Johnson, Alexander L, Kergaye, Ahmed A, McElroy, John F, Rohrbach, Kenneth W
Published in Journal of medicinal chemistry (01.11.1992)

Get full text

Journal Article

Short- and long-term effects of ovariectomy on food intake, body weight, carcass composition, and brown adipose tissue in rats

Short- and long-term effects of ovariectomy on food intake, body weight, carcass composition, and brown adipose tissue in rats

by McElroy, J.F, Wade, G.N
Published in Physiology & behavior (1987)

Get more information

Journal Article

Piperidinyltetralin .sigma. Ligands

Piperidinyltetralin .sigma. Ligands

by Gilligan, Paul J, Kergaye, Ahmed A, Lewis, Bryan M, McElroy, John F
Published in Journal of medicinal chemistry (01.02.1994)

Get full text

Journal Article

Behavioral and Pharmacological Validation of the Gerbil Forced-Swim Test : Effects of Neurokinin-I Receptor Antagonists

Behavioral and Pharmacological Validation of the Gerbil Forced-Swim Test : Effects of Neurokinin-I Receptor Antagonists

by WALLACE-BOONE, Tanya L, NEWTON, Amy E, WRIGHT, Robert N, LODGE, Nicholas J, MCELROY, John F
Published in Neuropsychopharmacology (New York, N.Y.) (2008)

Get full text

Journal Article

Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers

Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers

by McElroy, John F, Chorvat, Robert J
Year of Publication 23.11.2021

Get full text

Patent

CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING DISEASE CONDITIONS, INCLUDING METABOLIC DISORDERS AND CANCERS

CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING DISEASE CONDITIONS, INCLUDING METABOLIC DISORDERS AND CANCERS

by McElroy, John F, Chorvat, Robert J
Year of Publication 28.01.2021

Get full text

Patent

Effects of CRF sub(1) receptor antagonists and benzodiazepines in the Morris water maze and delayed non-matching to position tests

Effects of CRF sub(1) receptor antagonists and benzodiazepines in the Morris water maze and delayed non-matching to position tests

by Hogan, John B, Hodges, Donald B, Lelas, Snjezana, Gilligan, Paul J, McElroy, John F, Lindner, Mark D
Published in Psychopharmacology (01.04.2005)

Get full text

Journal Article

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

by McElroy, John F, Chorvat, Robert J
Year of Publication 14.04.2020

Get full text

Patent

The anxiolytic CRF(1) antagonist DMP696 fails to function as a discriminative stimulus and does not substitute for chlordiazepoxide in rats

The anxiolytic CRF(1) antagonist DMP696 fails to function as a discriminative stimulus and does not substitute for chlordiazepoxide in rats

by Lelas, Snjezana, Zeller, Kim L, Ward, Kathryn A, McElroy, John F
Published in Psychopharmacology (01.04.2003)

Get full text

Journal Article

1
2
3
4
5
6
7
8
9
Next
[9]